caVos biotherapeutics

caVos is an emerging genomic and data science company, developing novel drugs based on naturally occurring resistance mechanisms

Health and bio

caVos biotherapeutics has no funding amount on record yet; its latest known round is Seed (Mar 2026). Recent Funding first saw it on October 2, 2026.

Raise history

1. March 23, 2026
   Seed · amount undisclosed
   Source: crunchbase.com

Related bio health companies

• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026
• FFreyyaSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cavos-biotherapeutics.